The type specimens and type localities of the orangutans, genus Pongo Lacépède, 1799 (Primates: Hominidae)

peerreview_statement: The publishing and review policy for this title is described in its Aims & Scope. aims_and_scope_url: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=tnah20Uncertain type localities undermine orangutan nomenclature. Bequeathed to the British Museum, the holotype of Pongo pygmaeus, according to Hans Sloane’s catalogue, came from Borneo and died in China. The historical evidence makes Banjarmasin its most probable type locality. William Montgomerie, Assistant Surgeon at Singapore from 1819-1827, and Senior Surgeon from 1832, supplied the holotype of Simia morio. In 1836 an adult female orangutan reached Singapore alive from Pontianak, Borneo. The holotypes of S. morio, S. hendrikzii, S. straussii and P[ithecus] owenii probably had the same origin, as pirate attacks endangered visits to other Bornean coasts. Absent from Brunei and north Sarawak, Malaysia, throughout the Holocene, orangutans occur there only as Pleistocene subfossils at Niah. Pan vetus (the Piltdown mandible) probably came from Paku, Sarawak. We identify Pongo borneo Lacépède, 1799 as an objective senior synonym of P. wurmbii Tiedemann, 1808, correcting its type locality from Sukadana to near Pontianak. This is the earliest name for the western subspecies (previously thought nominotypical) unless Pithecus curtus, probably from the Sadong River, Sarawak, represents a separate subspecies. If so, the name Pongo borneo would transfer to the southern population west of the Kahayan River, genetically distinguished at species level from the Sumatran orangutan, P. abelii.This is an original manuscript / preprint of an article published by Taylor & Francis in Journal of Natural History on 20 July 2016, available online: http://www.tandfonline.com/10.1080/00222933.2016.1190414NHM Repositor

Disconnection between the default mode network and medial temporal lobes in post-traumatic amnesia

Post-traumatic amnesia is very common immediately after traumatic brain injury. It is characterised by a confused, agitated state and a pronounced inability to encode new memories and sustain attention. Clinically, post-traumatic amnesia is an important predictor of functional outcome. However, despite its prevalence and functional importance, the pathophysiology of post-traumatic amnesia is not understood. Memory processing relies on limbic structures such as the hippocampus, parahippocampus and parts of the cingulate cortex. These structures are connected within an intrinsic connectivity network, the Default Mode Network. Interactions within the Default Mode Network can be assessed using resting state functional magnetic resonance imaging, which can be acquired in confused patients unable to perform tasks in the scanner. Here we used this approach to test the hypothesis that the mnemonic symptoms of post-traumatic amnesia are caused by functional disconnection within the Default Mode Network. We assessed whether the hippocampus and parahippocampus showed evidence of transient disconnection from cortical brain regions involved in memory processing. 19 traumatic brain injury patients were classified into post-traumatic amnesia and traumatic brain injury control groups, based on their performance on a paired associates learning task. Cognitive function was also assessed with a detailed neuropsychological test battery. Functional interactions between brain regions were investigated using resting-state functional magnetic resonance imaging. Together with impairments in associative memory patients in post-traumatic amnesia demonstrated impairments in information processing speed and spatial working memory. Patients in post-traumatic amnesia showed abnormal functional connectivity between the parahippocampal gyrus and posterior cingulate cortex. The strength of this functional connection correlated with both associative memory and information processing speed and normalised when these functions improved. We have previously shown abnormally high posterior cingulate cortex connectivity in the chronic phase after traumatic brain injury, and this abnormality was also observed in patients with post-traumatic amnesia. Patients in post-traumatic amnesia showed evidence of widespread traumatic axonal injury measured using diffusion magnetic resonance imaging. This change was more marked within the cingulum bundle, the tract connecting the parahippocampal gyrus to the posterior cingulate cortex. These findings provide novel insights into the pathophysiology of post-traumatic amnesia and evidence that memory impairment acutely after traumatic brain injury results from altered parahippocampal functional connectivity, perhaps secondary to the effects of axonal injury on white matter tracts connecting limbic structures involved in memory processing

Contributions in honor of Guy G. Musser.

450 p. : ill. (some col.), maps ; 26 cm. "Issued December 15, 2009." Includes bibliographical references.Contents: They sort out like nuts and bolts : a scientific biography of Guy G. Musser / Michael D. Carleton -- Taxonomy, distribution, and natural history of the genus Heteromys ‪(‬Rodentia: Heteromyidae‪)‬ in central and eastern Venezuela, with the description of a new species from the Cordillera de la Costa / Robert P. Anderson and Eliécer E. Gutiérrez -- Review of the Oryzomys couesi complex ‪(‬Rodentia: Cricetidae: Sigmodontinae‪)‬ in western Mexico / Michael D. Carleton and Joaquin Arroyo-Cabrales -- The antiquity of Rhizomys and independent acquisition of fossorial traits in subterranean muroids / Lawrence J. Flynn -- A new species of Reithrodontomys, subgenus Aporodon ‪(‬Cricetidae: Neotominae‪)‬, from the highlands of Costa Rica, with comments on Costa Rican and Panamanian Reithrodontomys / Alfred L. Gardner and Michael D. Carleton -- Phylogenetic relationships of harpyionycterine megabats ‪(‬Chiroptera: Pteropodidae‪)‬ / Norberto P. Giannini, Francisca Cunha Almeida, and Nancy B. Simmons -- A new genus and species of small ‪"‬tree-mouse‪"‬ ‪(‬Rodentia, Muridae‪)‬ related to the Philippine giant cloud rats / Lawrence R. Heaney, Danilo S. Balete, Eric A. Rickart, M. Josefa Veluz, and Sharon A. Jansa -- Biodiversity and biogeography of the moss-mice of New Guinea : a taxonomic revision of Pseudohydromys ‪(‬Muridae: Murinae‪)‬ / Kristofer M. Helgen and Lauren E. Helgen -- Systematic revision of sub-Saharan African dormice ‪(‬Rodentia: Gliridae‪)‬. Part 2, Description of a new species of Graphiurus from the central Congo Basin, including morphological and ecological niche comparisons with G. crassicaudatus and G. lorraineus / Mary Ellen Holden and Rebecca S. Levine -- Descriptions of new species of Crocidura ‪(‬Soricomorpha: Soricidae‪)‬ from mainland Southeast Asia, with synopses of previously described species and remarks on biogeography / Paulina D. Jenkins, Darrin P. Lunde, and Clive B. Moncrieff -- The six opossums of Félix de Azara : identification, taxonomic history, neotype designations, and nomenclatural recommendations / Robert S. Voss, Philip Myers, François Catzeflis, Ana Paula Carmignotto, and Josefina Barreiro -- Skull and dentition of Willeumys korthi, nov. gen. et sp., a cricetid rodent from the Oligocene ‪(‬Orellan‪)‬ of Wyoming / John H. Wahlert

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.

BACKGROUND: Global development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, for selected locations, subnational cause-specific mortality beginning in the year 1980. Here we report an update to that study, making use of newly available data and improved methods. GBD 2017 provides a comprehensive assessment of cause-specific mortality for 282 causes in 195 countries and territories from 1980 to 2017. METHODS: The causes of death database is composed of vital registration (VR), verbal autopsy (VA), registry, survey, police, and surveillance data. GBD 2017 added ten VA studies, 127 country-years of VR data, 502 cancer-registry country-years, and an additional surveillance country-year. Expansions of the GBD cause of death hierarchy resulted in 18 additional causes estimated for GBD 2017. Newly available data led to subnational estimates for five additional countries-Ethiopia, Iran, New Zealand, Norway, and Russia. Deaths assigned International Classification of Diseases (ICD) codes for non-specific, implausible, or intermediate causes of death were reassigned to underlying causes by redistribution algorithms that were incorporated into uncertainty estimation. We used statistical modelling tools developed for GBD, including the Cause of Death Ensemble model (CODEm), to generate cause fractions and cause-specific death rates for each location, year, age, and sex. Instead of using UN estimates as in previous versions, GBD 2017 independently estimated population size and fertility rate for all locations. Years of life lost (YLLs) were then calculated as the sum of each death multiplied by the standard life expectancy at each age. All rates reported here are age-standardised

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

Background Previous evidence supports androgen deprivation therapy (ADT) with primary radiotherapy as initial treatment for intermediate-risk and high-risk localised prostate cancer. However, the use and optimal duration of ADT with postoperative radiotherapy after radical prostatectomy remains uncertain. Methods RADICALS-HD was a randomised controlled trial of ADT duration within the RADICALS protocol. Here, we report on the comparison of short-course versus long-course ADT. Key eligibility criteria were indication for radiotherapy after previous radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to add 6 months of ADT (short-course ADT) or 24 months of ADT (long-course ADT) to radiotherapy, using subcutaneous gonadotrophin-releasing hormone analogue (monthly in the short-course ADT group and 3-monthly in the long-course ADT group), daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as metastasis arising from prostate cancer or death from any cause. The comparison had more than 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 75% to 81% (hazard ratio [HR] 0·72). Standard time-to-event analyses were used. Analyses followed intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and ClinicalTrials.gov , NCT00541047 . Findings Between Jan 30, 2008, and July 7, 2015, 1523 patients (median age 65 years, IQR 60–69) were randomly assigned to receive short-course ADT (n=761) or long-course ADT (n=762) in addition to postoperative radiotherapy at 138 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 8·9 years (7·0–10·0), 313 metastasis-free survival events were reported overall (174 in the short-course ADT group and 139 in the long-course ADT group; HR 0·773 [95% CI 0·612–0·975]; p=0·029). 10-year metastasis-free survival was 71·9% (95% CI 67·6–75·7) in the short-course ADT group and 78·1% (74·2–81·5) in the long-course ADT group. Toxicity of grade 3 or higher was reported for 105 (14%) of 753 participants in the short-course ADT group and 142 (19%) of 757 participants in the long-course ADT group (p=0·025), with no treatment-related deaths. Interpretation Compared with adding 6 months of ADT, adding 24 months of ADT improved metastasis-free survival in people receiving postoperative radiotherapy. For individuals who can accept the additional duration of adverse effects, long-course ADT should be offered with postoperative radiotherapy. Funding Cancer Research UK, UK Research and Innovation (formerly Medical Research Council), and Canadian Cancer Society

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Background Previous evidence indicates that adjuvant, short-course androgen deprivation therapy (ADT) improves metastasis-free survival when given with primary radiotherapy for intermediate-risk and high-risk localised prostate cancer. However, the value of ADT with postoperative radiotherapy after radical prostatectomy is unclear. Methods RADICALS-HD was an international randomised controlled trial to test the efficacy of ADT used in combination with postoperative radiotherapy for prostate cancer. Key eligibility criteria were indication for radiotherapy after radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to radiotherapy alone (no ADT) or radiotherapy with 6 months of ADT (short-course ADT), using monthly subcutaneous gonadotropin-releasing hormone analogue injections, daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as distant metastasis arising from prostate cancer or death from any cause. Standard survival analysis methods were used, accounting for randomisation stratification factors. The trial had 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 80% to 86% (hazard ratio [HR] 0·67). Analyses followed the intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and ClinicalTrials.gov, NCT00541047. Findings Between Nov 22, 2007, and June 29, 2015, 1480 patients (median age 66 years [IQR 61–69]) were randomly assigned to receive no ADT (n=737) or short-course ADT (n=743) in addition to postoperative radiotherapy at 121 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 9·0 years (IQR 7·1–10·1), metastasis-free survival events were reported for 268 participants (142 in the no ADT group and 126 in the short-course ADT group; HR 0·886 [95% CI 0·688–1·140], p=0·35). 10-year metastasis-free survival was 79·2% (95% CI 75·4–82·5) in the no ADT group and 80·4% (76·6–83·6) in the short-course ADT group. Toxicity of grade 3 or higher was reported for 121 (17%) of 737 participants in the no ADT group and 100 (14%) of 743 in the short-course ADT group (p=0·15), with no treatment-related deaths. Interpretation Metastatic disease is uncommon following postoperative bed radiotherapy after radical prostatectomy. Adding 6 months of ADT to this radiotherapy did not improve metastasis-free survival compared with no ADT. These findings do not support the use of short-course ADT with postoperative radiotherapy in this patient population

A new species of Microgale (Insectivora, Tenrecidae) from eastern Madagascar with an unusual dentition. American Museum novitates ; no. 3067

11 p. : ill. ; 26 cm.Includes bibliographical references (p. 11

Description of a new species of Sylvisorex (Insectivora: Soricidae) from Tanzania

Volume: 47Start Page: 65End Page: 7

A new species of Microgale (Insectivora, Tenrecidae) from northeastern Madagascar. American Museum novitates ; ; no. 2910.

7 p. : ill. ; 26 cm.Bibliography: p. 7